Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 Signaling-Reference-Cited by-同舟云学术

Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 Signaling

Published:2016-10 Issue:4 Volume:17 Page:1113-1127
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Puttur Franz,Francozo Marcela,Solmaz Gülhas,Bueno Carlos,Lindenberg Marc,Gohmert Melanie,Swallow Maxine,Tufa Dejene,Jacobs Roland,Lienenklaus Stefan,Kühl Anja A.,Borkner Lisa,Cicin-Sain Luka,Holzmann Bernard,Wagner Hermann,Berod Luciana,Sparwasser Tim

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference60 articles.

1. Antiviral treatment of cytomegalovirus infection;Ahmed;Infect. Disord. Drug Targets,2011

2. Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infections;Alexandre;Front Microbiol,2014

3. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity;Andoniou;Nat. Immunol.,2005

4. Functional interactions between dendritic cells and NK cells during viral infection;Andrews;Nat. Immunol.,2003

5. Dendritic cells coordinate innate immunity via MyD88 signaling to control Listeria monocytogenes infection;Arnold-Schrauf;Cell Rep.,2014

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity;Immunity;2024-04

2. M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation;EMBO Molecular Medicine;2023-08-28

3. Toll-like receptors in cardiac hypertrophy;Frontiers in Cardiovascular Medicine;2023-04-11

4. Host Versus Virus: The Genetics in HCV Infection Leading to Treatment;Hepatitis C - Recent Advances;2023-02-17

5. M-CSF induces a coordinated myeloid and NK cell differentiation program protecting against CMV after hematopoietic cell transplantation;2023-02-01